The abstract is read at the publisher; the summary is JClub's.
Calpain inhibition in homozygous Casq2 R33Q/R33Q mice restores CASQ2 and TRDN protein levels and reduces ventricular tachycardia episodes, linking calpain-dependent TRDN loss to CPVT.
- Why it matters: Reduced couplon proteins in recessive CPVT are linked to calcium mishandling, but how CASQ2 and TRDN decrease and which proteolytic route drives arrhythmia remains unclear.
- What they did: The study combined proteomics with neonatal cardiomyocyte and adult mouse experiments, testing proteasome, autophagy, and calpain inhibition, plus biochemical substrate assays and TRDN overexpression.
- The result: Calpain inhibition decreased triggered activity in isolated cardiomyocytes and lowered ventricular tachycardia in vivo; TRDN was identified as a direct calpain substrate, with TRDN degradation preceding CASQ2 loss and TRDN overexpression increasing CASQ2 levels in mutant mice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.